Physician profile
Huiyi Chen
NPI 1851603609
$3,668.25
in general payments reported to CMS, 2019-2025
16 companies · $951 in 2025
The $951 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $146 · 2021: $217 · 2022: $387 · 2023: $760 · 2024: $834 · 2025: $951.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,544.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,843.17 | 2019-2025 | Hydrus Microstent, Clareon, Clareon Panoptix Pro |
| Abbvie INC. | $611.33 | 2022-2025 | Durysta, Lumigan, Alphagan P |
| Johnson & Johnson Surgical Vision, INC. | $292.97 | 2019-2025 | Tecnis Iol, Tecnis Simplicity, Tecnis Iol |
| Allergan, INC. | $178.96 | 2019-2022 | |
| Thea Pharma INC. | $128.60 | 2023-2025 | Iyuzeh |
| Kala Pharmaceuticals, INC. | $124.91 | 2019-2022 | |
| Recordati_rare_diseases_inc. | $112.00 | 2025 | Panhematin |
| Sight Sciences, INC. | $85.90 | 2024-2025 | Omni Surgical System |
| Tarsus Pharmaceuticals, INC. | $54.88 | 2025 | Xdemvy |
| Biotissue Holdings INC. | $52.01 | 2019-2020 | |
| Sun Pharmaceutical Industries INC. | $47.63 | 2024-2025 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $41.24 | 2019 | |
| Bausch & Lomb Americas INC. | $35.14 | 2024-2025 | Xiidra, Miebo |
| Amgen INC. | $21.16 | 2024 | Tepezza |
| Oyster Point Pharma, INC. | $20.03 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| New World Medical,INC. | $18.32 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Huiyi Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.